Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy

Saved in:

Bibliographic Details
Main Authors:	Reid Shaw, James J. Yoon, Hannah Johnston, Marta B. Davidson, Alexa J. Siddon, Rory M. Shallis, Evan C. Chen, Madelyn Burkart, Timothy S. Oh, Sunil G. Iyer, Ellen Madarang, Chandrasekar Muthiah, Joshua Kassner, Raajit K. Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin Abaza, Jacqueline S. Garcia, Vikas Gupta, Kristen M. Pettit, Olatoyosi Odenike, Anand A. Patel
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Blood Advances
Online Access:	http://www.sciencedirect.com/science/article/pii/S2473952925001119
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms
by: Leah A. Goldberg, et al.
Published: (2025-05-01)

CLASSIFICATION OF MPN
by: Haifa Kathrin Al-Ali
Published: (2025-07-01)

Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
by: Samuel J. Yates, et al.
Published: (2025-07-01)

The Hen or the Egg: Inflammatory Aspects of Murine MPN Models
by: Jonas S. Jutzi, et al.
Published: (2015-01-01)

Potential application of the bulk RNA sequencing in routine MPN clinics
by: Shenglong Li, et al.
Published: (2025-04-01)

Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML
by: Justin Watts, et al.
Published: (2025-07-01)

Non-essential role of S100A9 in hematopoiesis in primary MPN and MDS mouse models
by: Qinglin Li, et al.
Published: (2025-07-01)

Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis—A Case Report
by: Anthi Bouchla, et al.
Published: (2018-01-01)

Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab
by: Jan Philipp Bewersdorf, et al.
Published: (2025-06-01)

I-MPN: inductive message passing network for efficient human-in-the-loop annotation of mobile eye tracking data
by: Hoang H. Le, et al.
Published: (2025-04-01)

Elevated Vitamin B12 Levels in Myeloproliferative Neoplasm (MPN) Patients: A Potential Diagnostic and Prognostic Marker
by: Fadul A, et al.
Published: (2024-12-01)

Detection of Escherichia coli Contamination using Most Probable Number (MPN) methods in Chicken Meats in Market of Surabaya
by: Dhandy Koesoemo Wardhana, et al.
Published: (2021-04-01)

MPN/MDS OVERLAP SYNDROME ANTICIPATED BY A SEVERE BLEEDING DIATHESIS: HYPOTHESIS OF A PRE-EXISTING PLATELET DISORDER
by: Paola Ranalli, et al.
Published: (2024-08-01)

40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies
by: Kristen Corrao, et al.
Published: (2025-01-01)

DIAGNOSIS AND ANALYSIS OF HYPER-TUNING DEEP LEARNING MODEL FOR AUTOMATIC DIAGNOSING CELIAC DISEASE
by: Sreenivas Pratapagiri, et al.
Published: (2025-03-01)

MPN-RRT*: A New Method in 3D Urban Path Planning for UAV Integrating Deep Learning and Sampling Optimization
by: Yue Zheng, et al.
Published: (2025-07-01)

Unleashing immunity against oral cancer with immune checkpoint inhibitors
by: Ajay Guru
Published: (2024-06-01)

A Portable UV-LED/RGB Sensor for Real-Time Bacteriological Water Quality Monitoring Using ML-Based MPN Estimation
by: Andrés Saavedra-Ruiz, et al.
Published: (2025-04-01)

The Evolving Treatment Landscape of AML
by: Sabine Blum, et al.
Published: (2022-03-01)

Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact—a study of 784 patients from the Quebec MPN research group
by: Alisa Poullet, et al.
Published: (2025-04-01)

Natural fish swim bladder-derived MPN-nanofibrous biomimetic system exhibit ECM-responsive signal regulation and promote robust tendon–bone healing
by: Lei Shi, et al.
Published: (2025-07-01)

Epidemiology of Acute Myeloid Leukemia (AML)
by: Gengi Kleto, et al.

WHO HAS THERAPY-RELATED AML?
by: Robert Gale, et al.
Published: (2017-03-01)

SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
by: Francesco D'Alò, et al.
Published: (2011-11-01)

SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
by: Livio Pagano, et al.
Published: (2011-01-01)

Beat AML genetic risk stratification model in a cohort of older VEN/HMA-treated patients with AML
by: Fieke W. Hoff, et al.
Published: (2025-08-01)

Advancing AML Treatment: Evidence-Based Regimens and Guideline Updates for Targeted Treatments in R/R AML [Podcast]
by: Zeidan AM, et al.
Published: (2025-07-01)

Causal contextual bandits with one-shot data integration
by: Chandrasekar Subramanian, et al.
Published: (2024-12-01)

Mycobacterium shimoidei cavitary pneumonia: A rare case report, literature review
by: Siddartha Guru, et al.
Published: (2025-08-01)

Dependency-based fault diagnosis approach for SOA-based systems using Colored Petri Nets
by: Guru Prasad Bhandari, et al.
Published: (2022-02-01)

Optical control of ferroaxial order
by: Zhiren He, et al.
Published: (2024-12-01)

A Multidisciplinary Analysis of Adults Referred for Psychiatric Consultation in the Emergency Department: Clinical Insights from a Period of Over One Year on Demographic Characteristics and Outcomes
by: Meltem Gürü, et al.
Published: (2025-04-01)

Banana bunch image and video dataset for variety classification and gradingMendeley Data
by: D.S. Guru, et al.
Published: (2025-06-01)

Tele-neurosurgery: Expanding access and expertise through remote consultation and virtual surgery
by: Vanitha Marunganathan, et al.
Published: (2024-01-01)

Letter to the editor concerning “effects of Levetiracetam and Lacosamide on survival and seizure control in 2IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy” by Andrea Bianconi et al
by: Karthikeyan Kandaswamy, et al.
Published: (2024-01-01)

WHICH IS THE BEST TREATMENT FOR AML WITH RESTRICTED RESOURCES
by: Mipsang Lama
Published: (2025-07-01)

Bilateral Conjunctival Infiltration as an Extramedullary Relapse of AML
by: Zahra Mozaheb, et al.
Published: (2018-01-01)

Downregulation of stromal syntenin sustains AML development
by: Raphael Leblanc, et al.
Published: (2023-10-01)

Finding the right fit: assessment of fitness in AML
by: Nicholas Chornenki, et al.
Published: (2025-05-01)

AN AML CASE PRESENTING WITH EXTRAMEDULLARY MYELOID SARCOMA
by: Songül Beskisiz Dönen, et al.
Published: (2024-12-01)